Moreover, decreased Fpn1 expression in breast cancer patients was correlated with poor prognosis and metastasis, independent of other risk factors, and was proposed as a prognostic marker for this disease [39], indicating potentially important roles for the Fpn1-hepcidin regulatory axis in oncogenic signaling. This evidence concerns the gene SLC40A1 and breast cancer.